A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination with Other Anti-Cancer Therapies in Solid Tumors

Activity Type

Clinical Trial

Date

Mon, 07/01/2024 - 12:00

Dollar Amount

*

Grant Type

Contract

Principal Investigator

Jennifer Segar

Unit

Cancer Center Division